Impact of Histological Variants on Outcomes in Patients with Urothelial Carcinoma Treated with Pembrolizumab: a Propensity Score Matching Analysis
BJU International(2021)
Key words
urothelial cancer chemo-resistant,histological variant,sarcomatoid,immune checkpoint inhibitor,pembrolizumab
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined